Detailed price information for Akari Therapeutics ADR (AKTX-Q) from The Globe and Mail including charting and trades.
ASCO 2026 highlighted a shift toward precision-driven oncology R&D, where biomarkers, ctDNA, and integrated strategies guide ...
Tech Xplore on MSN
Programmable metasurface generates dozens of holograms at once
Over the past few decades, engineers have developed various devices that can create holograms, three-dimensional (3D) or ...
Granted claims cover the use of vafidemstat for treating non-aggressive symptoms of BPD U.S. patent to expire in March 2043, including 1,095 days ...
Potentially first-in-class oral TNIK inhibitor advances into late-stage development after milestones marked by vital ...
When Vera Therapeutics in-licensed atacicept from Merck KGaA about six years ago, patients with IgA nephropathy (IgAN) had no ...
Granted claims cover the use of vafidemstat for treating non-aggressive symptoms of BPDU.S. patent to expire in March 2043, including 1,095 days of Patent Term AdjustmentNotice of allowance also recei ...
Globally recognized leader in early-phase oncology clinical development and experimental therapeutics Strengthens strategic ...
New Preclinical Data Demonstrate Favorable Oral Bioavailability, Robust Brain Penetration and Liver Exposure with Once-Daily ...
6d
Cohere Technologies Wins $28 Million U.S. Government Contract to Develop Multi-Waveform RAN for ISAC
Multi-Waveform Wireless Prototype Will Deliver Operational Aerial Surveillance and Response ISAC is a mission-first ...
The experience of the GT3 Sport Cabriolet is only enhanced by the power-operated roof, but the big challenge will likely be ...
The 55th Annual Conference of the Fraunhofer Institute for Chemical Technology ICT, titled “Energetic Materials: From Simulation and Synthesis to Application – Ensuring Supply Security in a Changing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results